Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             44 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A Phase III Study of Surgical Resection and Paclitaxel/Carboplatin Chemotherapy with or Without Adjuvant Radiation Therapy for Resected Stage III Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B 9734 Perry, Michael C.
 2007
 8 Supplement 2 p. 268-272
5 p.
 artikel
2 A Phase II Study of Single-Agent Oral Vinorelbine in Patients with Pretreated Advanced Non–Small-Cell Lung Cancer Rossi, David
 2007
 8 Supplement 2 p. 382-385
4 p.
 artikel
3 A Randomized Phase II Study of Sorafenib/Gemcitabine or Sorafenib/Erlotinib for Advanced Non–Small-Cell Lung Cancer in Elderly Patients or Patients with a Performance Status of 2: Treatment Rationale and Protocol Dynamics Gridelli, Cesare
 2007
 8 Supplement 2 p. 396-398
3 p.
 artikel
4 Clinical and Molecular Responses in Lung Cancer Patients Receiving Romidepsin Schrump, D.S.
 2007
 8 Supplement 2 p. 453-
1 p.
 artikel
5 Clinical Development of Vandetanib: A Review of Ongoing Phase III Clinical Trials in Advanced NSCLC Heymach, J.
 2007
 8 Supplement 2 p. 446-
1 p.
 artikel
6 CyberKnife® Radiosurgery for Stage I Lung Cancer: Results at 36 Months Brown, William T.
 2007
 8 Supplement 2 p. 488-492
5 p.
 artikel
7 Different Epidermal Growth Factor Receptor Gene Mutations in a Patient with 2 Synchronous Lung Cancers Nakano, Hirofumi
 2007
 8 Supplement 2 p. 562-564
3 p.
 artikel
8 4-Dimensional Conformal Radiation Therapy: Image-Guided Radiation Therapy and its Application in Lung Cancer Treatment Park, Clint
 2006
 8 Supplement 2 p. 187-194
8 p.
 artikel
9 Dual Targeting of the Vascular Endothelial Growth Factor and Epidermal Growth Factor Receptor Pathways: Rationale and Clinical Applications for Non-Small-Cell Lung Cancer Byers, Lauren A.
 2007
 8 Supplement 2 p. S79-S85
7 p.
 artikel
10 Early Prediction of Response to Anticancer Therapy in Patients with Advanced/Metastatic Non–Small-Cell Lung Cancer Using FDG-PET-CT Lee, D.H.
 2007
 8 Supplement 2 p. 449-
1 p.
 artikel
11 Efficacy and Safety of Single-Agent Axitinib (AG-013736; AG) in Patients with Advanced Non–Small-Cell Lung Cancer (NSCLC): A Phase II Trial Schiller, J.H.
 2007
 8 Supplement 2 p. 452-
1 p.
 artikel
12 Epidermal Growth Factor Receptor Inhibitors plus Chemotherapy in Non–Small-Cell Lung Cancer: Biologic Rationale for Combination Strategies Gandara, David R.
 2007
 8 Supplement 2 p. S61-S67
7 p.
 artikel
13 Erlotinib as a Single Agent in Select Subsets of Patients with Advanced Non–Small-Cell Lung Cancer Carrión, Ramón Pérez
 2007
 8 Supplement 2 p. 425-428
4 p.
 artikel
14 Erlotinib Monotherapy for Stage IIIB/IV Non–Small-Cell Lung Cancer in Korea; Expanded Access Program for Patients Failing Previous Treatment(s) Park, B.-B.
 2007
 8 Supplement 2 p. 443-
1 p.
 artikel
15 Evaluation of the Use of Prophylactic Cranial Irradiation in Small-Cell Lung Cancer Patel, S.
 2007
 8 Supplement 2 p. 450-
1 p.
 artikel
16 Frontline Cytotoxic Chemotherapy (CTx) for Newly Diagnosed Non–Small-Cell Lung Cancer (NSCLC) Patients Presenting with Brain Metastasis Compared to Whole-Brain Radiotherapy (WBRT): Result of a Randomized Pilot Study Lee, D.H.
 2007
 8 Supplement 2 p. 448-
1 p.
 artikel
17 Gemcitabine/Carboplatin in a Modified 21-Day Administration Schedule for Advanced-Stage Non-Small-Cell Lung Cancer Yoshimura, Mana
 2006
 8 Supplement 2 p. 208-213
6 p.
 artikel
18 2007 Highlights from: the 12th World Conference on Lung Cancer Seoul, South Korea; September 2-6, 2007 Shivakumar, Latha
 2007
 8 Supplement 2 p. 526-531
6 p.
 artikel
19 K-ras Mutations in Non-Small-Cell Lung Carcinoma: A Review Aviel-Ronen, Sarit
 2006
 8 Supplement 2 p. 30-38
9 p.
 artikel
20 Long-Term Survival with Concurrent Chemoradiation Therapy Followed by Consolidation Docetaxel in Stage IIIB Non–Small-Cell Lung Cancer: A Phase II Southwest Oncology Group Study (S9504) Gandara, David R.
 2006
 8 Supplement 2 p. 116-121
6 p.
 artikel
21 Mature Results of a Phase II Trial of Gemcitabine/Paclitaxel Given Every 2 Weeks in Patients with Advanced Non–Small-Cell Lung Cancer Wozniak, Antoinette J.
 2007
 8 Supplement 2 p. 313-318
6 p.
 artikel
22 Metastatic Brain Mass Caused by Slow-Growing Small-Cell Lung Cancer: Differential Vascular Endothelial Growth Factor Expression in Primary and Metastatic Tumor Inoue, Satoshi
 2007
 8 Supplement 2 p. 436-438
3 p.
 artikel
23 Motexafin Gadolinium (MGd) is Active as a Single Agent and in Combination with Pemetrexed and Docetaxel in Advanced Non–Small-Cell Lung Cancer (NSCLC) Patients who Failed Platinum-Based Chemotherapy: Early Results of 3 Phase II Trials Natale, R.B.
 2007
 8 Supplement 2 p. 455-
1 p.
 artikel
24 Novel Small-Molecule Inhibitors of the Vascular Endothelial Growth Factor Receptor Adjei, Alex A.
 2007
 8 Supplement 2 p. S74-S78
5 p.
 artikel
25 Open, Randomized, Phase II Study of Single-Agent Gemcitabine and Docetaxel as First- and Second-Line Treatment in Patients with Advanced Non–Small-Cell Lung Cancer Manegold, Christian
 2007
 8 Supplement 2 p. 245-251
7 p.
 artikel
26 Paclitaxel/Carboplatin/Gemcitabine Versus Gemcitabine/Vinorelbine in Advanced Non–Small-Cell Lung Cancer: A Phase II/III Study of the Minnie Pearl Cancer Research Network Greco, F. Anthony
 2007
 8 Supplement 2 p. 483-487
5 p.
 artikel
27 Phase II Study of Continuous Daily Sunitinib Dosing in Patients with Previously Treated Advanced Non–Small-Cell Lung Cancer (NSCLC) Scagliotti, G.V.
 2007
 8 Supplement 2 p. 451-
1 p.
 artikel
28 Phase II Trial of Bevacizumab plus Pemetrexed and Carboplatin in Previously Untreated Advanced Nonsquamous Non–Small-Cell Lung Cancer Dalsania, C.
 2007
 8 Supplement 2 p. 444-
1 p.
 artikel
29 Phase II Trial of Concurrent Paclitaxel, Carboplatin, and External-Beam Radiation Followed by Surgical Resection in Locally Advanced Non–Small-Cell Lung Cancer, Protocol 99-444 Fischer, Sean A.
 2006
 8 Supplement 2 p. 56-61
6 p.
 artikel
30 Phase II Trial of Sequential Chemotherapy Followed by Chemoradiation, Surgery, and Postoperative Chemotherapy for the Treatment of Stage IIIA/IIIB Non-Small-Cell Lung Cancer Lam, Prudence
 2006
 8 Supplement 2 p. 122-129
8 p.
 artikel
31 Polyuria and Polydipsia in a Patient with Non–Small-Cell Lung Cancer Jung, Jae Wook
 2007
 8 Supplement 2 p. 565-567
3 p.
 artikel
32 Prognostic Factors in Stage III Non–Small-Cell Lung Cancer Ademuyiwa, Foluso O.
 2007
 8 Supplement 2 p. 478-482
5 p.
 artikel
33 Prognostic Value of Apoptosis-Associated Speck-like Protein Containing a CARD Gene Promoter Methylation in Resectable Non-Small-Cell Lung Cancer Zhang, Zhixue
 2006
 8 Supplement 2 p. 62-65
4 p.
 artikel
34 Randomized, Multicenter, Open-Label Phase II Study of Gemcitabine plus Single-Dose Versus Split-Dose Carboplatin in the Treatment of Patients with Advanced-Stage Non-Small-Cell Lung Cancer Schuette, Wolfgang
 2006
 8 Supplement 2 p. 135-139
5 p.
 artikel
35 Results and Impact of Routine Assessment of Comorbidity in Elderly Patients with Non–Small-Cell Lung Cancer Aged > 80 Years Breen, David
 2007
 8 Supplement 2 p. 331-334
4 p.
 artikel
36 Review of Pulmonary Hemorrhage (PH) in Non–Small-Cell Lung Cancer (NSCLC) Subjects Receiving Bevacizumab and Cisplatin plus Gemcitabine on Protocol BO17704 LaFleur, F.
 2007
 8 Supplement 2 p. 447-
1 p.
 artikel
37 Safety of Bevacizumab Therapy in Subjects with Brain Metastases due to Non–Small-Cell Lung Cancer (NSCLC) Hainsworth, J.
 2007
 8 Supplement 2 p. 445-
1 p.
 artikel
38 Safety of Bevacizumab Treatment in Non–Small-Cell Lung Cancer (NSCLC) Subjects Receiving Full-Dose Anticoagulation (FDAC) Treated on Protocol BO17704 Skillings, J.
 2007
 8 Supplement 2 p. 454-
1 p.
 artikel
39 Safety of Irinotecan/Cisplatin Versus Etoposide/Cisplatin for Patients with Extensive-Stage Small-Cell Lung Cancer: A Metaanalysis Jiang, Lei
 2007
 8 Supplement 2 p. 497-501
5 p.
 artikel
40 Salvage Therapy with Vinorelbine in Advanced Non-Small-Cell Lung Cancer: A Retrospective Review of the Fox Chase Cancer Center Experience and a Review of the Literature Devlin, John G.
 2007
 8 Supplement 2 p. 319-326
8 p.
 artikel
41 Schedule-Dependent Apoptosis in K-ras Mutant Non–Small-Cell Lung Cancer Cell Lines Treated with Docetaxel and Erlotinib: Rationale for Pharmacodynamic Separation Mahaffey, Christopher M.
 2007
 8 Supplement 2 p. 548-553
6 p.
 artikel
42 The Potential of Death Receptor 4– and 5–Directed Therapies in the Treatment of Lung Cancer Camidge, D. Ross
 2007
 8 Supplement 2 p. 413-419
7 p.
 artikel
43 Topotecan Therapy in Patients with Relapsed Small-Cell Lung Cancer and Poor Performance Status Lilenbaum, Rogerio C.
 2006
 8 Supplement 2 p. 130-134
5 p.
 artikel
44 Tumor Lysis Associated with Sudden Onset of Syndrome of Inappropriate Antidiuretic Hormone Secretion Saintigny, Pierre
 2007
 8 Supplement 2 p. 282-284
3 p.
 artikel
                             44 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland